Click2PrintAE®, an end-to-end digital workflow for 3D printed ocular prosthetics

Ocupeye成立于2016年，是一家总部位于英国的中小企业，拥有一支由设计，工程和商业专家领导的创新，有远见的辅助设备创新团队。Moorfields Eye Charity致力于为医疗保健行业带来积极变革，这一强烈的雄心促使我们踏上了为义眼创建3D打印工艺的旅程，这不仅可以降低医院成本和劳动时间，还可以优先考虑患者的舒适度、满意度和义眼的贴合度。全球有超过800万人佩戴义眼，英国有7万人佩戴义眼。尽管医疗保健领域的其他技术取得了进步，但目前向患者提供眼部假体的过程在70多年来基本保持不变，目前眼部假体的模制、成形、着色和安装都是采用20世纪50年代的技术手工完成的。这个过程是侵入性的，通常对患者造成创伤，特别是对儿童，需要注射藻酸盐来制作患者眼睛形状的蜡模。然后手工绘制、组装和抛光假肢，这是耗时的，需要高度熟练的资源。等待名单的时间因COVID-19而加剧，选择性护理的等待名单人数从440万增加到600万人[NHS交付计划]。为了解决这些问题，Ocupeye将向市场推出全球首个用于3D打印和制造义眼的端到端数字流程。这一过程将是非侵入性的，不接触患者，并将等待时间从60周大幅缩短至3周，同时更快速有效地为医疗保健提供急需的创新生命科学产品。

Incorporated in 2016, Ocupeye are a UK-based SME with an innovative, visionary team of assistive devices innovators led by design, engineering, and business experts. Our strong ambition to drive positive change within the healthcare industry has led us on a journey to create a 3D printing process for prosthetic eyes that not only reduces hospital costs and labour time, but prioritises patient comfort, satisfaction, and prosthetic fit.Over 8 million people worldwide and 70k in the UK wear a prosthetic eye \[Moorfields Eye Charity\]. Despite technological advancements elsewhere in healthcare, the current process to supply ocular prosthetics to patients has remained largely unchanged for over 70 years, with ocular prosthetics currently moulded, shaped, painted, and fitted individually by hand with techniques from the 1950s. The process is invasive and often traumatic for patients, particularly for children, with alginate injections required to make wax patterns for patient's eye shapes. Prosthetics are then hand-painted, assembled, and polished, which is time-consuming and requires highly skilled resource. Waiting list time been exacerbated by COVID-19, with waiting list numbers for elective care increased from 4.4 million to 6 million people \[NHS Delivery Plan\]. This greatly impacts patient care, satisfaction, and overall quality of life.To address these issues, Ocupeye will bring to market the world's first end-to-end digital process for the 3D printing and manufacture of prosthetic eyes. The process will be non-invasive and no-touch to patients and significantly reduce the extortionate waiting list time from 60 weeks to a 3-week turnaround, whilst delivering a much-needed, innovative life sciences product into healthcare more quickly and effectively.